Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: Prophylactic NAC promoted hematopoietic reconstitution by improving endothelial cells after haploidentical HSCT: a phase 3, open-label randomized trial

Fig. 3

Prophylactic NAC improved BM ECs and CD34+ cells in EC<0.1% group post-HSCT. The dynamic reconstitution (left panel) and statistical analysis (right panel) of a BM EC percentage, b EC ROS level, c CD34+ cell percentage, and d CD34+ cell ROS level were analyzed by flow cytometry among the three groups before randomization (−24 days), at the time of conditioning initiation (−10 days), and +14, +30, +60 days post-HSCT. The data are expressed as the mean and SEM. P ≤ 0.05 was considered statistically significant and values are provided in the figure (*P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, **** P ≤ 0.0001)

Back to article page